3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
3
Urogenital Neoplasms
1
Smoldering Multiple Myeloma
1
Sarcoma
1
Prostatic Neoplasms
1
Peripheral Nervous System Diseases
1
Neoplasms
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypertension
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Depressive Disorder, Major
1
Depression
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Interventions
Cryotherapy
2
Vitamin D
1
Vitamin B 6
1
Vitamin B 12
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Glutamine
1
Fatty Acids, Omega-3
1
Epoetin Alfa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Peripheral Nervous System Diseases
×
Fatty Acids, Omega-3
×
Clear all
NCT02795572
2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2
Terminated
13 enrolled